awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
J.MVR.2005.01.002
J.MVR.2005.01.002
http://dx.doi.org/10.1016/J.MVR.2005.01.002
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.
P356
Q46409873-398E7425-CF45-4623-82D7-360E04B44E65
P356
J.MVR.2005.01.002
http://dx.doi.org/10.1016/J.MVR.2005.01.002